跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
TRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 21, 2022
Approval ID
93916bde06016481
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
93916bde06016481
Drug Cima Aemps Name
TRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
86917
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2022-04-21
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
1 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
TRABECTEDINA
1 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 21, 2022
Approval ID
93916bde06016481
Type
Standard
Back to CIMA-AEMPS Approvals